Smiths Medical ASD Inc. recalls CADD-Solis Ambulatory Infusion Pumps
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- CADD-Solis Ambulatory Infusion Pumps, with software versions before v4.3, may have the following issues:1. Upstream Occlusion, 2. Stop and Power Keys Unresponsive, 3. Manual Mode Air Detector, 4. Single Bubble Air Detection, 5. Error Codes Not Displayed at Power Up, 6. Audible Alarm, 7. Low Sensitivity Air in Line Detection Threshold, 8. PharmGuard Server Password. Smiths Medical corrected many of the issues included in this notification in previous software updates and the corrections were carried forward into all subsequent software releases. Please ensure you have the most recent CADD software (v4.3 - 2023) installed on your pumps.
- Products
-
- CADD-Solis Ambulatory Infusion Pumps
- Company
- Smiths Medical ASD Inc.
- Where it was sold
-
Worldwide
Nationwide
- Barcodes
306105860353371061058603295010610586035548306105860353441061058603535730610586035368106105860353951061058603540110610586035418106105860354251061058603544910610586035456106105860354631061058603548710610586035494106105860318543061058603551130610586035528106105860355311061058603394010610586033933- Units affected
- 9284 units
- About this recall
- CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.